Xoran receives FDA clearance for Tron, begins study

2022 08 05 18 25 3168 2022 08 05 Xoran Tron 400

CT developer Xoran Technologies said it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's Tron mobile fluoroscopy/CT scanner.

Xoran's Tron mobile CT/fluoroscopy system.Xoran's Tron mobile CT/fluoroscopy system.

Tron is a mobile unit that can be installed in vans or wheeled to patients and can produce scans in under a minute, the company said. Xoran believes the system will "democratize" access to medical imaging.

Xoran also recently began work on the second phase of a mobile lung research project with the goal of confirming the safety and utility of a future thoracic point-of-care CT system in support of an FDA submission. The company said that these efforts in lung CT are supported by a recent grant award from the U.S. National Heart, Lung, and Blood Institute (NHLBI) through the National Institutes of Health (NIH).

Page 1 of 655
Next Page